Skip to main content
. 2018 Dec 21;63(1):e00822-18. doi: 10.1128/AAC.00822-18

FIG 2.

FIG 2

Pharmacodynamics of tedizolid against MRSA ATCC 33591 in immunocompetent (IC) and neutropenic (immunosuppressed [IS]) mice. Mice were inoculated with 2.4 × 107 CFU/thigh (IC) or 7 × 105 CFU/thigh (IS). Veh, vehicle.